Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAbbotts XIENCE V Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS Liberte in Investigator-Initiated COMPARE Trial
Abbott, 09/24/09
Late–breaking data presented from the COMPARE trial demonstrated that Abbott's market–leading XIENCE V Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS Liberte Paclitaxel–Eluting Coronary Stent System.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis Tasigna trial shows superior results to Glivec in patients with early-stage chronic myeloid leukemia
Novartis, 12/09/09
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/08/09
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Sponsor
Article Search
Sponsor